Diabetes Mellitus, Inflammation, Obesity: Proposed Treatment Pathways for Current and Future Therapies

Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice

(2009) Kathryn Moynihan Ramsey et al.   AGING CELL

Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis

(2009) N. EJSKJAER et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Resveratrol Improves Endothelial Function

(2009) Hanrui Zhang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Mechanisms of resveratrol-induced platelet apoptosis

(2009) K. H. Lin et al.   CARDIOVASCULAR RESEARCH

Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin Resistance

(2009) Lale Ozcan et al.   Cell Metabolism

Ghrelin and Metabolic Disorders

(2009) Olavi Ukkola   CURRENT PROTEIN & PEPTIDE SCIENCE

Enhanced Gastrointestinal Motility with Orally Active Ghrelin Receptor Agonists

(2009) S. Charoenthongtrakul et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus

(2009) Takahiro Araki et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Motilin and ghrelin as prokinetic drug targets

(2009) Betty De Smet et al.   PHARMACOLOGY & THERAPEUTICS

The potential of ghrelin as a prokinetic

(2009) Pierre Poitras et al.   REGULATORY PEPTIDES

Targeting the ghrelin receptor to regulate food intake

(2009) Inge Depoortere   REGULATORY PEPTIDES

Effects of Telmisartan and Ramipril on Adiponectin and Blood Pressure in Patients with Type 2 Diabetes

(2008) C. Delles et al.   AMERICAN JOURNAL OF HYPERTENSION

Therapeutic potential of resveratrol in Alzheimer's disease

(2008) Valérie Vingtdeux et al.   BMC NEUROSCIENCE

Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-Induced Metabolic Disorders by Enhancing Fat Oxidation

(2008) Jérôme N. Feige et al.   Cell Metabolism

The role of ghrelin and ghrelin analogues in wasting disease

(2008) Mayra M Kamiji et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Economic Costs of Diabetes in the U.S. in 2007

(2008)   DIABETES CARE

Ghrelin: a new peptide regulating the neurohormonal system, energy homeostasis and glucose metabolism

(2008) Peter Pusztai et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Ghrelin in Pathological Conditions

(2008) Simoni A. KATERGARI et al.   ENDOCRINE JOURNAL

Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis

(2008) Christopher D. Mann et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B

(2008) Balachandar Venkatesan et al.   FASEB JOURNAL

Ghrelin Agonist (TZP-101): Safety, Pharmacokinetics and Pharmacodynamic Evaluation in Healthy Volunteers: A Phase I, First-in-Human Study

(2008) Kenneth C. Lasseter et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Oral administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation

(2008) a. d. shafton et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis

(2008) Katsuya Dezaki et al.   PHARMACOLOGY & THERAPEUTICS

Ghrelin improves delayed gastrointestinal transit in alloxan-induced diabetic mice

(2008) Wen-Cai Qiu et al.   WORLD JOURNAL OF GASTROENTEROLOGY